| PERIOD ENDING | 31-Dec-08 | | Total Revenue | 50,908,000 | | Cost of Revenue |
-
| | | Gross Profit | 50,908,000 | | | Operating Expenses | | Research Development |
-
| | Selling General and Administrative | 3,017,000 | | Non Recurring | 1,349,000 | | Others | 57,771,000 | | | | Total Operating Expenses |
-
| | | | Operating Income or Loss | (11,229,000) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| | Earnings Before Interest And Taxes | (11,237,000) | | Interest Expense | 33,332,000 | | Income Before Tax | (44,569,000) | | Income Tax Expense | 5,550,000 | | Minority Interest | (8,000) | | | | Net Income From Continuing Ops | (50,119,000) | | | Non-recurring Events | | Discontinued Operations |
-
| | Extraordinary Items |
-
| | Effect Of Accounting Changes |
-
| | Other Items |
-
| | | | Net Income | (50,119,000) | | Preferred Stock And Other Adjustments | (676,000) | | | Net Income Applicable To Common Shares | ($50,795,000) |
|
0.07% Nasdaq 
Income Statement
